Online Application Offers a Secure Location for Exiqon Diagnostics to Deliver
Test Reports and Content Directly to Oncologists.
Exiqon today announced the beta test launch of their new proprietary PortiQo™
Doctor Portal, a communication tool that will electronically connect clients to
Exiqon Diagnostics. The PortiQo™ platform allows secure communication with
physicians though a web-based portal system. The system was developed to
enhance efficiency, improve quality and streamline the reporting process. As a
leader in personalizing medicine for cancer patients, the company is committed
to bringing value-added services to its clients, such as the new PortiQo™
system, to help improve patient care and cancer management.
The PortiQo™ Doctor Portal is currently in the initial phases (beta testing)
with a limited number of U.S. physicians and medical centers participating in
the program. Beta site features are currently limited to regularly updated
on-line results reporting with full-color images which can be printed or stored
for later reference. The system automatically alerts the ordering physician
when there is a test result available for review.
At a later date, once the beta testing is complete, portal access will be
granted to physicians on a larger scale. Over time, increased functionality
will be realized in future phases of the portal system as new capabilities are
added for online test ordering, renewal of standing orders, fulfillment of
requests for supplies and media, and other bi-directional communication
functions. This user-friendly system allows physicians to gather patient test
results quickly and efficiently and helps to improve patient care.
Robert W. Holloway, M.D., gynecologic oncologist at Florida Hospital Cancer
Institute, said: “The PortiQo Doctor Portal will enhance Exiqon's already
strong position in the market for targeted anticancer therapies by helping the
company deliver better information to doctors, faster.”
“With the beta test launch of the new PortiQo™ Doctor Portal, Exiqon has
developed an important new platform that increases our ability to efficiently
interact with physicians,” said R. Erik Holmlin, Chief Commercial Officer,
Exiqon Diagnostics. “We expect the service to allow us to better serve our
physician customers and, by extension, their patients by delivering critical
test information more rapidly. Over time, as the services available through
PortiQo Doctor Portal expand, we think it's going to prove to be an invaluable
tool to oncologists.”
To learn more about Exiqon's PortiQo™ system, please visit
www.exiqondiagnostics.com. To request portal access, please contact client
services at 1-800-662-6832.
Additional information:
Lars Kongsbak, CEO, tel. +45 45 66 08 88 (cell: +45 40 90 21 01)
R. Erik Holmlin, CCO, tel. +1-714-566-0470
Exiqon Diagnostics Client Services, tel. +1-800-662-6832
See full press release in the attached PDF.
